BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Vestaron Announces First Product Submission to EPA


7/17/2012 9:11:59 AM

KALAMAZOO, MI--(Marketwire - July 17, 2012) -

Vestaron Corporation announces submission of its first biopesticide to the Biopesticide and Pollution Prevention Division of the US EPA. Their first product, a bioinsecticide derived from natural sources, is targeted at crop-destroying chewing insects. The product submission includes use on vegetables, tree fruit and nuts, vines, turf and other non-crop areas, nurseries as well by homeowners.

This new biopesticide provides levels of control expected from commercial insecticides. The product will give specialty crop growers not only a new option for control of a major class of insect pests, but also a new mode of action to strengthen their resistance management strategy.

"It is exciting to submit a biopesticide product with a novel mode of action that can be integrated into insect resistance management programs," said Robert Kennedy, Ph.D., Vestaron's Chief Scientific Officer. "There are still many situations in which new solutions are needed for successful insect control."

The bioinsecticide recently submitted to the EPA is the first portfolio product that Vestaron has developed from its library of novel natural peptides. The company recently received notification that the submission had just passed through both the Completeness Screen and Submission Readiness Team (SRT) review. The SRT is a technical screen of the submission to determine if it is complete for routing for scientific review. This starts the clock for the legislatively mandated 16 month review.

About Vestaron Corporation
Vestaron is developing a new generation of insecticides using natural peptides. Products under development have a unique mode of action, are highly effective against insects and related pests and are harmless to non-target species, including humans. Target markets include agriculture, animal health and specialty non-crop uses such as household insects. Vestaron cleantech products will be ideally suited for the environmentally conscious twenty-first century. For more information visit www.vestaron.com.

Forward-Looking Statements

This press release contains certain "forward-looking" statements within the meaning of the Private Securities Litigation Reform Act of 1995. Information in this press release, which is not historical, is forward looking and involves a number of risks and uncertainties. Investors are cautioned not to put any undue reliance on any forward-looking statement. Vestaron's actual results may differ materially from Vestaron's historical results of operations and those discussed in the forward-looking statements for various reasons, including, but not limited to Vestaron's ability to carry out its business plan, successful development and commercial acceptance of its products, ability to fund development necessary for existing products and for the pursuit of new product opportunities, ability to hire required personnel, the risk of whether products result from development activities, protection of Vestaron's intellectual property portfolio, the risk associated with obtaining the necessary regulatory approvals, the ability to obtain foreign regulatory approvals for products and to establish marketing arrangements in countries where approval is obtained, and other potential factors.


Steven Hartmeier
Email Contact
269-372-3108



Read at BioSpace.com

EPA
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES